| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9237724 | Digestive and Liver Disease | 2005 | 5 Pages |
Abstract
The continuous use of topical mesalazine associated with a high oral dosage significantly improves the clinical course of ulcerative colitis patients at high risk of relapse.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
G. Frieri, M. Pimpo, B. Galletti, G. Palumbo, G. Corrao, G. Latella, M. Chiaramonte, R. Caprilli,